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ABSTRACT
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Reproductive Issues of Women with Epilepsy
There are about 10 million people with epilepsy in India and a quarter of them are 
women in reproductive age group. The social stigma of epilepsy has pervasive impact 
on the life of people with epilepsy particularly women. The cyclical hormonal changes 
during menstrual cycle and during pregnancy can inﬂuence the seizure pattern in 
women with epilepsy. Exposure to antiepileptic drugs (AEDs) can increase the risk of 
fetal malformations in the infants. This risk is higher with polytherapy and valproate in 
higher doses. A small proportion of children with antenatal AED exposure can have 
problems with cognitive development. All women with epilepsy need to have 
preconception evaluation to simplify the treatment of epilepsy. It is preferable to avoid 
valproate as an AED antiepileptic drug in women who are planning pregnancy.
Keywords : Epilepsy, pregnancy,  antiepileptic drugs,  fetal malformation,  infertility, 
cognition.
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INTRODUCTION
 Epilepsy is a disease known to 
humanity from time immemorial. The 
earliest documentation of epilepsy is in 
the Babylonian text on Medicine, Sakikku 
which was written before BC 1000. These 
stone tablets are saved in the British 
Museum at London. They have described 
epilepsy as Miqtu as a collection of what 
we today label as generalized tonic clonic 
seizures, absences, drop attacks and focal 
seizures  with  or  without  loss  of 
awareness. They had even described the 
Jacksonian march of focal motor seizures 
and seizures characterized by myrthless 
laughter (gelastic seizures) (1).  It was ﬁve 
hundred year later (BC 500) that 
Hippocrates had broken the myth of 
supernatural causation of epilepsy. In his 
text book he has described epilepsy as a 
disorder of the brain (2). Indian system of 
medicine had documented epilepsy in 
detail as early as 6 - 2nd century BC. 
Indian physicians interpreted epilepsy 
(apasmara) as a disorder of brain that leads 
t o  d i s t u r b a n c e  i n  m e m o r y  o r 
consciousness. Similarly there are 
detailed description of epilepsy in 
prehistoric literature from central and 
south America (3) and Africa (4).
Burden of epilepsy :
 Epilepsy is one of the most 
common serious neurological disorders in 
the world. It is estimated that there are 
about 70 million people with epilepsy in 
the world. There are several studies on 
prevalence of epilepsy from different 
parts of India. However there is much 
variation in the deﬁnition, survey 
methodology, level of ascertainment etc. 
A  m e t a  a n a l y s i s  o f  s e v e r a l 
epidemiological studies from different 
parts of India had shown that the corrected 
prevalence of active epilepsy per 1000 
population was 5.59 with 95% conﬁdence 
interval ranging from 4.15 to 7.03. 
Prevalence was higher in rural areas and 
among men when compared to urban 
areas and women (5).   A recent meta 
analysis has shown that the median 
incidence of epilepsy was 50.4 per 
100,000 population per year (Inter 
quartile range was 33.6 - 75.7=6). The 
incidence in low income countries was 
higher 81.7 (IQR 28-239.5) when 
compared to high income countries  45.0 
(IQR 30.5 - 66.7). This includes one study 
from India (6) by Late Prof. K.S. Mani, the 
father of Indian modern epileptology. 
 Globally it accounts for 17 million 
disability adjusted life years (DALY) lost 
which amounts to 1% of all DALY. More 
than 90% of these are reported from low 
and middle income countries.  Epilepsy 
causes a major economic burden to the 
country. The cost of epilepsy from a 
nations perspective consists of Direct cost 
related to Medical expenditures, hospital 
services, home care services and ancillary 
services. Another component of direct 
cost is the cost of the care provided by the 
family and friends, cost of transportation 
a n d  h o u s e k e e p i n g .  T h e  s e c o n d 
component of the cost is the Indirect cost 
related to loss of productivity and earnings 
by way of  absence f rom gainful 
employment, income lost by family 
members etc. A third dimension to the cost 
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of a disease is the Intangible cost 
attributed to the pain, suffering and social 
stigma which is often not taken in to 
consideration while computing the cost of 
an illness. We carried out a multi centric 
study of the cost of epilepsy in India which 
is the yard stick that WHO often use for 
the developing world (7). Although the 
cost of epilepsy in terms of dollars may be 
low because of the low monetary value of 
Indian Rupees, it constituted more than 
80% of the per capita GNP at that time. 
More than 70% of  the cost of epilepsy 
was due to indirect component which 
could be reduced substantially by 
improving the direct services for 
diagnosis and treatment of epilepsy. It 
appears that it is a wise economic decision 
to invest more on the treatment of epilepsy 
in order as it is likely to yield considerable 
savings from lower indirect cost.  
Women and epilepsy :
 Epilepsy affects men and women 
in equal  proportions.  Yet women 
experience the consequences of epilepsy 
more than men. The social stigma of 
epilepsy has more profound effect on 
women (8).  It was observed that the 
stigma has several levels.  On an 
individual level it leads to lower self 
esteem, withdrawal, self imposed 
isolation and a tendency to internalize 
shame. On a social level it inﬂuences 
social variables such as social integration, 
social networking and peer group 
activities. Lastly on a community level it 
leads to difﬁculties in arranging marriage 
or secure a job.  In a survey carried out in 
Kerala state, 31% and 27% thought 
epilepsy was a hereditary disorder and a 
form of insanity, respectively. About 40% 
of the respondents felt that individuals 
with epilepsy could not be properly 
educated or employed (9).  As a result 
women have more difﬁculty in ﬁnding a 
life partner and getting a job. In a direct 
comparison of men and women matched 
for age and type of epilepsy it was 
observed that comorbidities, lower 
employment and higher anxiety state were 
more frequent for WWE compared to 
MWE. Females had more difﬁculty in 
ﬁnding life partners compared to males. 
Women with epilepsy (WWE) were at 
increased risk of divorce (10).  The 
treatment gap is wider for women than for 
men with epilepsy (11). This gap is even 
wider when the women live in villages. 
Infertility :
 On biological terms epilepsy can 
lead to a variety of medical situations. A 
survey that compared WWE attending to a 
tertiary care centre in south India with the 
women in general in the Kerala state the 
former had more abortions, smaller family 
size and greater proportion of women with 
no living child (12). A subsequent 
prospective study had conﬁrmed that 
WWE enrolled in the Kerala Registry of 
Epilepsy and Pregnancy had higher risk of 
infertility (38.4%) compared to age 
matched women in Kerala State (15%). 
Their family size (0.6) was one third that 
of women in general (1.87). The risk of 
infertility increased as the number of 
AEDs  were increased (13). In a follow up 
study it was also observed that in this 
registry women with infertility had 
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abnormal  hormonal  proﬁle  when 
compared to women who had pregnancy 
(14).   This was characterized by higher 
testosterone level abnormal LH/FSH ratio 
and lower progesterone levels in the blood 
which mimic the anovulatory ovarian 
cycles and PCOS. In a recent study at our 
Institute we had observed that 24 % of 
WWE fulﬁlled the ATP III criteria for 
Metabolic Syndrome (15). 
Epilepsy and Pregnancy :
 P regnancy  can  modi fy  the 
epilepsy in a large proportion of women. 
Progesterone, the predominant hormone 
in pregnancy has favourable effects that 
reduce the seizure frequency as it has 
antiepileptic properties. In contrast the 
blood level of several antiepileptic drugs, 
particularly lamotrigine, oxcarbazepine 
and levetiracetam are likely to drop 
considerably in the second and third 
trimester of pregnancy as their clearance 
is increased several folds. Data from the 
KREP indicates that of the 1,297 
pregnancies in WWE with complete 
seizure data, 47.8% were seizure free 
during pregnancy. Some 15% of women 
may experience seizure aggravation 
during pregnancy. Seizure relapse was 
highest during the three peripartum days. 
Women with partial seizures or on 
polytherapy had higher risk of relapse 
(16). 
 A variety of complications of 
pregnancy appear to be increased in WWE 
such as spontaneous abortion, pregnancy 
induced hypertension, antepartum or post 
partum haemorrhage, caesarean section 
and preterm labour (17).  Data from the 
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Table 1. Comparison of the epilepsy and pregnancy registries 
Country
 
UK 
 
US 
 
KREP* 
 
EUROPE
 
#
 
Australia
year
  
1996
  
1997
  
1998
  
1999
  
2000
  
Preconception 
cases
 
No
  
No
  
Yes
  
No
  
No
  
Women not on 
AEDs  
Yes
  
No
  
Yes
  
No
  
Yes
  
Exclusion  AED 
change  
  AED 
change   
 
Data  collection  2 contacts  3 contacts  4 contacts   4 contacts   4  (phone)
Outcome 
ascertained at 
<12 wks  < 12 wks  12 months  
12 years   
12 months   12 months
Control
  
Internal
  
External
  
Non 
epilepsy 
 
External
 
&
 
Internal
  
Internal
 
Internal&
External
* Kerala Registry of Epilepsy and Pregnancy
 # European registry of antiepileptic drugs and  pregnancy which also has data coming 
from south and central America, Japan, Kerala and Australia.
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KREP point towards increased risk of 
spontaneous abortion, gestational 
hypertension, pre-eclampsia and anemia 
in WWE when compared to healthy 
women (18). 
 T h e  m a l f o r m a t i o n  r i s k  o f 
antenatal exposure to antiepileptic drug 
exposure was ﬁrst noticed in the 1960s. 
Since then it had been observed that most 
AEDs carried increased risk of fetal 
malformation. Systematic prospective 
collection of data on the malformation risk 
for pregnancies in WWE were began with 
the pregnancy registry in UK in 1996. This 
was followed by setting up of registry in 
the North America (1997),  Kerala (1998),  
Europe (1999) and Australia (2000). Most 
of registries enrol WWE during the ﬁrst 
trimester of pregnancy and complete the 
data collection by 3rd or 12th post partum 
month. The Kerala Registry of Epilepsy 
and Pregnancy is unique in enrolling 
women in the preconception stage or in 
ﬁrst trimester and following up their 
children till the age of 18 years (Table 1).
 The overall major malformation 
rate in the UK registry for all AED 
exposed cases was 4.2% (95% conﬁdence 
interval (CI),  3.6% to 5.0%).  The rates in 
the Kerala registry was 7.1% (95% CI 
5.98 - 8.44). The risk of MCM with 
polytherapy is signiﬁcantly higher than 
that  of  monotherapy.  Among the 
monotherapy exposures those exposed to 
Valproate had signiﬁcantly higher risk of 
MCM. Recent studies have shown that the 
malformation risk increased as the dose of 
AEDs increased,  part icularly for 
valproate, levetiracetam, lamotrigine, 
cabrbamazepine and phenobarbitone 
( 1 9 ) .  T h e  c o m m o n l y  r e p o r t e d 
malformations are given in table 2.
Sanjeev V. Thomas 
Table 2. Commonly encountered malformations in children 
with antenatal exposure to antiepileptic drugs
Cardiac
Atrial septal defect
 
Ventricular Septal defect
 
Patent Ductus Arteriosus
 
Tetrology of Fallot  
Double outlet ventrible
 
Nervous system
 Meningo myelocoele
 
Spina biﬁda
 
Neural tube defect
 
Microcephaly
 
Skeletal
 
Cleft lip
 
Cleft palate
 
Tallipes equinovarus
 
Renal
 
Agenesis of kidney
 
Hydronephrosis
Pelviureteric junction obstruction
Posterior Urethral valve
Hyposadias
GIT
Omphalocoele
Cyst in Liver
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 The malformation risk of sodium 
valproate is signiﬁcantly higher than that 
of other AEDs according to the data from 
all the pregnancy registries. As a result it is 
now recommended not to use valproate as 
the ﬁrst drug of choice in newly diagnosed 
epilepsy in girls and women with 
childbearing potential.
Cognitive developmental issues of 
children with antenatal exposure to 
AEDs :
 The negative impact of antenatal 
exposure to AEDs on the cognitive 
development of children had been the 
focus of research in the recent past. The 
KREP had been prospectively following 
up a large cohort of such children from 
birth till adolescence. The setting of the 
pregnancy registry enabled us to acquire 
data on the maternal characteristics, AED 
usage during pregnancy, complications of 
pregnancy and neonatal status in a 
prospective manner. Evaluation of these 
children at one year of age had shown that 
there is increased risk of motor or mental 
developmental delay in children with 
prenatal AED exposure. The risk was 
higher for those with polytherapy or 
valproate therapy (20).  Further follow up 
of this cohort at six years showed that they 
had signiﬁcantly lower IQ and language 
performance when compared to school 
children without antenatal AED exposure 
(21).  This cohort continued to show 
impairment in IQ, visual reproduction and 
frontal lobe function when evaluated 
between 10 - 12 years of age (22). The 
language functions of children with 
antenatal exposure to Phenobarbitone was 
signiﬁcantly lower than that of children 
with exposure to carbamazepine or low 
dose valproate (Fig. 1).
 A retrospective analysis of 
children aged 5 - 9 years with prenatal 
exposure to levetiracetam, topiramate or 
valproate monotherapy showed that those 
exposed to higher doses of valproate had 
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Fig. 1 : Bar chart showing the mean score with standard deviation for the 
language functions on children with antenatal exposure to different 
antiepileptic drugs as monotherapy. (PB= Phenobarbitone; PHT=Phenytoin; 
CBZ= Carbamazepine; VPA= valproate)
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lower performance on several yardsticks 
of cognitive function when compared to 
other AEDs (23). Data from the NEAD 
study (Neurodevelopmental Effects of 
Antiepileptic Drugs study) have also 
conﬁrmed that children with AED 
exposure, particularly those exposed to 
high dose valproate had signiﬁcantly 
lower IQ when evaluated at one year, three 
years (24, 25)  and six years of age (26).  
Another retrospective study had shown 
that those exposed to valproate as mono or 
polytherapy had higher risk of additional 
educational needs at school when 
c o m p a r e d  t o  t h o s e  e x p o s e d  t o 
carbamazepine (27). These data have 
given a clear signal that antenatal 
exposure to valproate particularly at 
h i g h e r  d o s e  c a n  l e a d  t o 
neurodevelopmental problems in children 
that may persist even to older age.  Some 
of these issues can lead to practical 
difﬁculties with education and social 
adaptation.
Conclusion :
 E p i l e p s y  i s  a  c o m m o n 
neurological problem in the community. It 
has considerable ramiﬁcations in the 
biological, developmental, and social 
domains for the affected person and the 
family. WWE are exposed to these 
difﬁculties to a greater extent than men. 
WWE in the reproductive age have 
additional health problems related to 
pregnancy and structural and cognitive 
development of their children. Exposure 
to sodium valproate as an antiepileptic 
drug in pregnancy can lead to increased 
risk of fetal malformation and cognitive 
development. Preconception counselling 
and optimization of treatment of epilepsy 
is the key to improve the pregnancy 
outcome for WWE. It is important to 
highlight the fact that more than 90 per 
cent of WWE can expect safe pregnancy 
and healthy babies.  All women need to 
have a systematic antenatal evaluation and 
screening for fetal malformation. 
Children of WWE need to be followed up 
for possible cognitive developmental 
impairments so that remedial measures 
could be instituted as soon as required. 
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